Focus: Levisonics is a hematology-focused biotech company developing a novel platform for blood coagulation analysis and fluid rheological measurement. Founded in 2016 and based in Fishers, Indiana, the company operates as a publicly-traded entity with a specialized technology approach.
Profile data last refreshed 13h ago · AI intelligence enriched 5d ago
Early-stage platform biotech with interesting technology but unproven clinical path—best fit for engineers/scientists comfortable with undefined timelines and limited scale.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Levisonics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Levisonics's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/moBased on last 4 crawl cycles